An interventional study of Aggregated data collection and Data collection and qualitative interview in Suicidality and COVID -19, sponsored by Hospices Civils de Lyon. Recruiting at 4 sites in France. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-18.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Health services research
In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.
Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).
Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.
The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.
515 studies on the registry are indexed under Suicidal Ideation; 195 are open to participants now.
This study's planned enrollment of 6,500 is above the median of 80 across 426 interventional studies indexed under Suicidal Ideation.
Browse Suicidal Ideation studies →Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The population (subjects and controls) will be divided into age categories:
Subjects with suicidal behavior during the health crisis (Group 1):
Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):
Controls with suicidal behavior before the health crisis (Group 2):
Exclusion Criteria:
- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):
Controls with Suicidal Behavior before the Health Crisis (Group 2):
For Group 1:
* Name : Group 1 * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022. * Age ≥ 8 years old and \< 18 years old between 2020 and 2022.
Other: Aggregated data collection
* Name : Group 1b * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents * Age ≥ 8 years old and \< 18 years old between 2020 and 2022 for subjects. * One or both parents * Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects). * Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.
Other: Data collection and qualitative interview
* Name: group 2 * Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region * Age ≥ 8 years old and \< 18 years old between 2018 and 2019
Other: Aggregated data collection
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.
Demographic and diagnostic characteristics
The following demographic and diagnostic characteristics will be collected in aggregate form for the entire population of children and adolescents who engaged in suicidal behavior during the health crisis and in the two preceding years: * Age, gender, place of residence, * ICD-10 diagnosis and referral, * Type of suicidal behavior (ideation, self-harm, suicide attempt), * Periods of social restrictions (lockdown, curfew, vaccine pass).
Time frame: Baseline
Number of patients aged 8-17 and 11month admitted to pediatric emergency
Number of patients aged 8-17 and 11month admitted to pediatric emergency rooms or hospitalized in a continuous care/intensive care unit of university hospitals (CHU) or general hospitals (CH) for suicidal behavior during the COVID-19 pandemic period of 2020, 2021, and 2022, and those in the two preceding years: 2018 and 2019.
Time frame: Baseline
Psychopathological and socio-economic characteristics
The following psychopathological and socio-economic characteristics will be collected: * Age, sex, place of residence, * Family situation and intrafamilial relationships * Type of suicidal behavior and description (ideation, self-harm, suicide attempt) * Periods of social restrictions (lockdown, curfew, vaccination pass) * Leisure time and type of leisure activities/hobbies * Education * Relationship with peers * Previous and current psychiatric diagnosis (according to ICD-10) * Personal and family psychiatric history * Personal medical history * Pharmacological and psychological treatment; Type of care
Time frame: Baseline
Scores to CRIES
Scores on the Children's Revised Impact of Events Scale (CRIES-13) (Horowitz et al., 1979; Brunet et al., 2003) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Time frame: Up to 3 months
CAS scale
Scores on the Climate Anxiety Scale (CAS) (Clayton and Karazsia, 2020; Mouguiama-Daouda et al., 2022) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Time frame: Up to 3 months
Qualitative interview
Semi-structured interviews with children and adolescents with suicidal behavior from a representative sample of the cohort. Subjects who agreed to interviews. We will try to have a sample of volunteers from Group 1 who can be representative of our population (care orientation, age, personal psychiatric history, and place of residence.)
Time frame: Up to 3 months
Results to focus groups (parent's subjects, group 1b)
Focus groups with the parents of children and adolescents with suicidal behavior from a representative sample of the cohort (randomly selected).
Time frame: Up to 3 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospices Civils de Lyon